Drug Shortage Report for APO-OXYBUTYNIN
Report ID | 183474 |
Drug Identification Number | 02163543 |
Brand name | APO-OXYBUTYNIN |
Common or Proper name | OXYBUTYNIN |
Company Name | APOTEX INC |
Market Status | MARKETED |
Active Ingredient(s) | OXYBUTYNIN CHLORIDE |
Strength(s) | 5MG |
Dosage form(s) | TABLET |
Route of administration | ORAL ORAL |
Packaging size | 100 BTL |
ATC code | G04BD |
ATC description | OTHER UROLOGICALS, INCL ANTISPASMODICS |
Reason for shortage | Disruption of the manufacture of the drug. |
Anticipated start date | |
Actual start date | 2023-01-31 |
Estimated end date | 2023-04-28 |
Actual end date | 2023-04-26 |
Shortage status | Resolved |
Updated date | 2023-04-27 |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 150 SIGNET DRIVE TORONTO, ONTARIO CANADA M9L 1T9 |
Company contact information | Apotex Customer Service - 1-877-427-6839 |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v15 | 2023-04-27 | French | Compare |
v14 | 2023-04-27 | English | Compare |
v13 | 2023-04-21 | French | Compare |
v12 | 2023-04-21 | English | Compare |
v11 | 2023-03-30 | French | Compare |
v10 | 2023-03-30 | English | Compare |
v9 | 2023-03-23 | French | Compare |
v8 | 2023-03-23 | English | Compare |
v7 | 2023-03-23 | English | Compare |
v6 | 2023-02-23 | French | Compare |
v5 | 2023-02-23 | English | Compare |
v4 | 2023-02-09 | French | Compare |
v3 | 2023-02-09 | English | Compare |
v2 | 2023-02-02 | French | Compare |
v1 | 2023-02-02 | English | Compare |
Showing 1 to 15 of 15